Contact
    Start Publications Polysaccharide Multilayer Films in Sensors for Detecting ...
    ←  Publication Finder
    KSV NIMA

    Polysaccharide Multilayer Films in Sensors for Detecting Prostate Tumor Cells Based on Hyaluronan-CD44 Interactions

    Year: 2020

    Journal: Cells, Volume 9, JUN

    Authors: Neto, JBMR; Soares, AC; Bataglioli, RA; Carr, O; Costa, CAR; Oliveira, ON; Beppu, MM; Carvalho, HF

    Organizations: CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [465699/2014-6, 147536/2016-2]; Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/18953-8, 2016/10193-9, 2018/22214-6, 2018/20560-4]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/50938-8]

    Keywords: hyaluronan; cancer; CD44 receptor; sensing; layer-by-layer films; information visualization

    The increasing need for point-of-care diagnosis has sparked the development of label-free sensing platforms, some of which are based on impedance measurements with biological cells. Here, interdigitated electrodes were functionalized with layer-by-layer (LbL) films of hyaluronan (HA) and chitosan (CHI) to detect prostatic tumor cells (PC3 line). The deposition of LbL films was confirmed with atomic force microscopy and polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS), which featured the vibrational modes of the HA top layer capable of interacting specifically with glycoprotein CD44 receptors overexpressed in tumor cells. Though the CHI/HA LbL films cannot be considered as a traditional biosensor due to their limited selectivity, it was possible to distinguish prostate tumor cells in the range from 50 to 600 cells/mu L in in vitro experiments with impedance spectroscopy. This was achieved by treating the impedance data with information visualization methods, which confirmed the distinguishing ability of the films by observing the absence of false positives in a series of control experiments. The CD44-HA interactions may, therefore, be exploited in clinical analyses and point-of-care diagnostics for cancer, particularly if computational methods are used to process the data.
    View publication